药石科技: 关于调整2025年度日常关联交易预计的公告

Group 1 - The company has adjusted its estimated daily related party transactions for the year 2025, increasing the total expected amount from 79.6 million yuan to include an additional 1.5 million yuan for sales to a related party [1][2][3] - The revised expected amount for sales of goods and services to Jiangsu Nanchuang Chemical and Life Health Research Institute Co., Ltd. has increased from 1 million yuan to 2.5 million yuan [1][3] - The adjustments were approved by the company's independent directors before being submitted to the board for review, ensuring compliance with relevant regulations [2][6] Group 2 - The company’s total expected related party transactions for 2025 include purchasing goods and services up to 2.6 million yuan, selling goods and providing services up to 75.3 million yuan, and renting assets and paying utility fees up to 1.7 million yuan [1][2] - The related party, Jiangsu Nanchuang Chemical and Life Health Research Institute Co., Ltd., has a registered capital of 12.6111 million yuan and is involved in the research, production, and sales of pharmaceuticals and medical devices [3][4] - The company confirms that the pricing for these transactions is based on market rates and does not harm the interests of non-related shareholders [5][6]